Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia
MedPage Today) — An investigational anti-CD38 monoclonal antibody (CM313) rapidly increased platelets in immune thrombocytopenia (ITP) patients to levels sufficient for preventing bleeding, a small single-arm Chinese study showed.
In the phase…
Read More
